The study, entitled The Opioid Epidemic: Fixing a Broken Pharmaceutical Market, arguesthat non-rigorous patenting standards and ineffectual policing of both fraudulent marketing and anticompetitive actions played an important role in the opioid epidemic. These regulatory issues are not unique to prescription opioids but are reflective of the wider pharmaceutical market.


